Fidan, CihanAydogdu, Ayse2021-05-162021-05-1620200306-9877http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7211747&blobtype=pdfhttp://hdl.handle.net/11727/5865It has been hypothesized that Montelukast, a cysteinyl leukotriene (cysLT) receptor antagonist, with effects of anti-inflammatory, suppress oxidative stress and reduce affect cytokine production, may limited progression of the disease on COVID-19 infection.enginfo:eu-repo/semantics/openAccessletter1420005651956000192-s2.0-85084495386